Aclarion Stock Z Score
| ACON Stock | USD 0.18 0.01 5.88% |
Aclarion | Z Score |
Aclarion Company Z Score Analysis
Aclarion's Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
| |||||||
| |||||||
| |||||||
| |||||||
|
Aclarion Z Score Driver Correlations
Understanding the fundamental principles of building solid financial models for Aclarion is extremely important. It helps to project a fair market value of Aclarion Stock properly, considering its historical fundamentals such as Z Score. Since Aclarion's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Aclarion's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Aclarion's interrelated accounts and indicators.
Click cells to compare fundamentals
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
| Competition |
In accordance with the company's disclosures, Aclarion has a Z Score of 0.0. This is 100.0% lower than that of the Health Care Equipment & Supplies sector and about the same as Health Care (which currently averages 0.0) industry. The z score for all United States stocks is 100.0% higher than that of the company.
Aclarion Institutional Holders
Institutional Holdings refers to the ownership stake in Aclarion that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Aclarion's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Aclarion's value.| Shares | Geode Capital Management, Llc | 2024-06-30 | 42.1 K | Ubs Group Ag | 2024-06-30 | 39.9 K | Two Sigma Securities, Llc | 2024-06-30 | 32.1 K | Citadel Advisors Llc | 2024-06-30 | 28.8 K | Tower Research Capital Llc | 2024-06-30 | 9.2 K | Bank Of America Corp | 2024-06-30 | 167 | Ground Swell Capital, Llc | 2024-09-30 | 0.0 | Wells Fargo & Co | 2024-06-30 | 0.0 | Virtu Financial Llc | 2024-06-30 | 0.0 | Hrt Financial Llc | 2024-06-30 | 0.0 |
Aclarion Fundamentals
| Return On Equity | -7.14 | ||||
| Return On Asset | -1.15 | ||||
| Operating Margin | (103.51) % | ||||
| Current Valuation | 1.44 M | ||||
| Shares Outstanding | 10.43 M | ||||
| Shares Owned By Insiders | 9.76 % | ||||
| Shares Owned By Institutions | 3.57 % | ||||
| Number Of Shares Shorted | 428.83 K | ||||
| Price To Book | 0.73 X | ||||
| Price To Sales | 33.99 X | ||||
| Revenue | 75.4 K | ||||
| Gross Profit | (4.85 K) | ||||
| EBITDA | (4.14 M) | ||||
| Net Income | (4.91 M) | ||||
| Cash And Equivalents | 3.79 M | ||||
| Cash Per Share | 0.49 X | ||||
| Total Debt | 1.13 M | ||||
| Current Ratio | 3.18 X | ||||
| Book Value Per Share | (0.88) X | ||||
| Cash Flow From Operations | (3.65 M) | ||||
| Short Ratio | 0.77 X | ||||
| Earnings Per Share | (2.40) X | ||||
| Target Price | 1.25 | ||||
| Beta | 0.4 | ||||
| Market Capitalization | 1.83 M | ||||
| Total Asset | 2.46 M | ||||
| Retained Earnings | (44.28 M) | ||||
| Working Capital | (1.9 M) | ||||
| Net Asset | 2.46 M |
About Aclarion Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Aclarion's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aclarion using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aclarion based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
When determining whether Aclarion is a strong investment it is important to analyze Aclarion's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Aclarion's future performance. For an informed investment choice regarding Aclarion Stock, refer to the following important reports: Check out Aclarion Piotroski F Score and Aclarion Valuation analysis. To learn how to invest in Aclarion Stock, please use our How to Invest in Aclarion guide.You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aclarion. If investors know Aclarion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aclarion listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.40) | Revenue Per Share 0.015 | Quarterly Revenue Growth (0.36) | Return On Assets (1.15) | Return On Equity (7.14) |
The market value of Aclarion is measured differently than its book value, which is the value of Aclarion that is recorded on the company's balance sheet. Investors also form their own opinion of Aclarion's value that differs from its market value or its book value, called intrinsic value, which is Aclarion's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aclarion's market value can be influenced by many factors that don't directly affect Aclarion's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aclarion's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aclarion is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aclarion's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.